KDA Group (TSXV:KDA) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is KDA Group Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


KDA Group  (TSXV:KDA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


KDA Group Cyclically Adjusted PS Ratio Related Terms


KDA Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for KDA Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KDA Group Cyclically Adjusted PS Ratio Chart

KDA Group Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.82 0.98

KDA Group Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.63 0.63 0.54 0.30

TSXV:KDA vs VEEV, BTSG, TEM: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, KDA Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KDA Group Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, KDA Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where KDA Group's Cyclically Adjusted PS Ratio falls into.



KDA Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

KDA Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 is calculated as:

For example, KDA Group's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=0/132.7364*132.7364
=0.000

Current CPI (Apr. 2026) = 132.7364.

KDA Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 0.071 101.844 0.093
201610 0.197 102.002 0.256
201701 0.194 102.318 0.252
201704 0.147 103.029 0.189
201707 0.195 103.029 0.251
201710 0.111 103.424 0.142
201801 0.133 104.056 0.170
201804 0.104 105.320 0.131
201807 0.131 106.110 0.164
201810 0.115 105.952 0.144
201901 0.098 105.557 0.123
201904 0.092 107.453 0.114
201907 0.085 108.243 0.104
201910 0.048 107.927 0.059
202001 0.053 108.085 0.065
202004 0.046 107.216 0.057
202007 0.048 108.401 0.059
202010 0.045 108.638 0.055
202101 0.048 109.192 0.058
202104 0.047 110.851 0.056
202107 0.048 112.431 0.057
202110 0.038 113.695 0.044
202201 0.045 114.801 0.052
202204 0.001 118.357 0.001
202207 0.000 120.964 0.000
202210 0.001 121.517 0.001
202301 0.000 121.596 0.000
202304 0.000 123.571 0.000
202307 0.000 124.914 0.000
202310 0.000 125.310 0.000
202401 0.000 125.072 0.000
202404 0.000 126.890 0.000
202407 0.000 128.075 0.000
202410 0.000 127.838 0.000
202501 0.000 127.443 0.000
202504 0.000 129.102 0.000
202507 0.000 130.290 0.000
202510 0.001 130.603 0.001
202601 0.001 130.366 0.001
202604 0.000 132.736 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


KDA Group Business Description

Other Exchanges KDAGF:USAO1M:Germany
Address 1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.